Radnor Capital Management LLC purchased a new stake in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 12,545 shares of the health services provider's stock, valued at approximately $2,873,000.
Several other institutional investors have also added to or reduced their stakes in UHS. Financial Management Professionals Inc. purchased a new position in shares of Universal Health Services in the 3rd quarter worth approximately $32,000. Blue Trust Inc. boosted its holdings in shares of Universal Health Services by 1,284.6% in the 2nd quarter. Blue Trust Inc. now owns 180 shares of the health services provider's stock worth $33,000 after purchasing an additional 167 shares during the period. Innealta Capital LLC purchased a new position in shares of Universal Health Services in the 2nd quarter worth approximately $35,000. Headlands Technologies LLC purchased a new position in shares of Universal Health Services in the 1st quarter worth approximately $36,000. Finally, LRI Investments LLC purchased a new position in shares of Universal Health Services in the 1st quarter worth approximately $43,000. Hedge funds and other institutional investors own 86.05% of the company's stock.
Universal Health Services Stock Down 4.1 %
Shares of UHS traded down $8.65 during trading hours on Wednesday, hitting $203.52. The company had a trading volume of 1,443,493 shares, compared to its average volume of 680,836. The company has a market capitalization of $13.58 billion, a PE ratio of 13.46, a price-to-earnings-growth ratio of 0.67 and a beta of 1.29. The company has a current ratio of 1.39, a quick ratio of 1.28 and a debt-to-equity ratio of 0.69. Universal Health Services, Inc. has a one year low of $127.43 and a one year high of $243.25. The company's fifty day moving average price is $226.24 and its two-hundred day moving average price is $203.45.
Universal Health Services (NYSE:UHS - Get Free Report) last released its quarterly earnings results on Thursday, October 24th. The health services provider reported $3.71 EPS for the quarter, missing the consensus estimate of $3.75 by ($0.04). Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%. The company had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.90 billion. During the same period in the previous year, the firm posted $2.55 earnings per share. The company's revenue was up 11.3% on a year-over-year basis. As a group, equities analysts forecast that Universal Health Services, Inc. will post 15.89 earnings per share for the current fiscal year.
Universal Health Services announced that its board has authorized a stock buyback plan on Wednesday, July 24th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the health services provider to reacquire up to 8% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its shares are undervalued.
Analysts Set New Price Targets
A number of brokerages recently issued reports on UHS. The Goldman Sachs Group raised their price target on Universal Health Services from $200.00 to $229.00 and gave the stock a "buy" rating in a research note on Tuesday, July 30th. TD Cowen decreased their price target on Universal Health Services from $283.00 to $275.00 and set a "buy" rating for the company in a research note on Monday, October 28th. Wells Fargo & Company raised their price target on Universal Health Services from $275.00 to $285.00 and gave the stock an "overweight" rating in a research note on Wednesday. Barclays raised their price target on Universal Health Services from $256.00 to $271.00 and gave the stock an "overweight" rating in a research note on Friday, October 25th. Finally, Robert W. Baird raised their price target on Universal Health Services from $236.00 to $274.00 and gave the stock an "outperform" rating in a research note on Wednesday, September 4th. Six analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, Universal Health Services currently has an average rating of "Moderate Buy" and a consensus price target of $231.14.
Get Our Latest Analysis on UHS
Insider Buying and Selling
In related news, Director Warren J. Nimetz sold 3,444 shares of the business's stock in a transaction on Monday, August 12th. The stock was sold at an average price of $217.64, for a total transaction of $749,552.16. Following the transaction, the director now directly owns 3,971 shares in the company, valued at $864,248.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 16.10% of the stock is owned by company insiders.
Universal Health Services Profile
(
Free Report)
Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.
See Also
Before you consider Universal Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Universal Health Services wasn't on the list.
While Universal Health Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.